Search

Your search keyword '"Hirnschall, G"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Hirnschall, G" Remove constraint Author: "Hirnschall, G"
43 results on '"Hirnschall, G"'

Search Results

1. A global investment framework for the elimination of hepatitis B

2. Linking the Integrated Management of Childhood Illness (IMCI) and health information system (HIS) classifications: issues and options

3. WEAD0302: Total Control of Epidemic (TCE) program of Humana People to People: a community driven response to the fight against AIDS

4. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

5. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

6. Linking the integrated management of childhood illness (IMCI) and health information system (HIS) classifications: issues and options

7. A global investment framework for the elimination of hepatitis B.

8. WHO's path to elimination of mother-to-child transmission of HIV and syphilis.

9. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.

10. Ensuring Children and Adolescents Are Not Left Behind.

11. The WHO public health approach to HIV treatment and care: looking back and looking ahead.

12. The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action.

13. Monitoring HIV Treatment and the Health Sector Cascade: From Treatment Numbers to Impact.

14. Translating Technical Support Into Country Action: The Role of the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children in the Global Plan Era.

15. Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV response.

16. The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda.

17. Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings.

18. Introducing INSPIRE: an implementation research collaboration between the Department of Foreign Affairs, Trade and Development Canada and the World Health Organization.

19. HIV and HCV: distinct infections with important overlapping challenges.

20. Developing the 2013 WHO consolidated antiretroviral guidelines.

21. Health systems implications of the 2013 WHO consolidated antiretroviral guidelines and strategies for successful implementation.

22. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

23. Prices paid for adult and paediatric antiretroviral treatment by low- and middle-income countries in 2012: high, low or just right?

24. Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models.

25. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

27. The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities.

28. Innovative device methods for adult medical male circumcision for HIV prevention: lessons from research.

29. Modelling the strategic use of antiretroviral therapy for the treatment and prevention of HIV.

30. The next generation of the World Health Organization's global antiretroviral guidance.

32. Is Option B+ the best choice?

33. Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples.

34. WHO and the future of disease control programmes.

35. Treatment 2.0: catalyzing the next phase of treatment, care and support.

36. Scale-up of HIV treatment through PEPFAR: a historic public health achievement.

38. HIV treatment as prevention: how scientific discovery occurred and translated rapidly into policy for the global response.

39. Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting.

40. Antiretroviral therapy in prevention of HIV and TB: update on current research efforts.

41. Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis.

42. Treatment 2.0: catalysing the next phase of scale-up.

43. Towards an improved investment approach for an effective response to HIV/AIDS.

Catalog

Books, media, physical & digital resources